These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32751954)

  • 1. Distinguishing and Biochemical Phenotype Analysis of Epilepsy Patients Using a Novel Serum Profiling Platform.
    Hanas JS; Hocker JRS; Vannarath C; Evangeline B; Prabhakaran V; Oommen A; Couch J; Anderson M; Rajshekhar V; Carabin H; Drevets D
    Brain Sci; 2020 Jul; 10(8):. PubMed ID: 32751954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing patients with idiopathic epilepsy from solitary cysticercus granuloma epilepsy and biochemical phenotype assessment using a serum biomolecule profiling platform.
    Hanas JS; Hocker JRS; Evangeline B; Prabhakaran V; Oommen A; Rajshekhar V; Drevets DA; Carabin H
    PLoS One; 2020; 15(8):e0237064. PubMed ID: 32823271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing Alzheimer's Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis.
    Hanas JS; Hocker JRS; Vannarath CA; Lerner MR; Blair SG; Lightfoot SA; Hanas RJ; Couch JR; Hershey LA
    Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33946285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing and phenotype monitoring of traumatic brain injury and post-concussion syndrome including chronic migraine in serum of Iraq and Afghanistan war veterans.
    Hanas JS; Hocker JRS; Lerner MR; Couch JR
    PLoS One; 2019; 14(4):e0215762. PubMed ID: 31026304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.
    Hocker JR; Peyton MD; Lerner MR; Mitchell SL; Lightfoot SA; Lander TJ; Bates-Albers LM; Vu NT; Hanas RJ; Kupiec TC; Brackett DJ; Hanas JS
    Lung Cancer; 2011 Nov; 74(2):206-11. PubMed ID: 21529985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing neurocysticercosis epilepsy from epilepsy of unknown etiology using a minimal serum mass profiling platform.
    Hanas JS; Hocker JR; Ramajayam G; Prabhakaran V; Rajshekhar V; Oommen A; Manoj JJ; Anderson MP; Drevets DA; Carabin H
    Exp Parasitol; 2018 Sep; 192():98-107. PubMed ID: 30096291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
    Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
    Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating experimental Listeria monocytogenes infections in mice using serum profiling.
    Hocker JR; Drevets DA; Dillon MJ; Hanas JS
    Appl Microbiol Biotechnol; 2012 Nov; 96(4):1049-58. PubMed ID: 23053068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer.
    Lu ZL; Chen YJ; Jing XY; Wang NN; Zhang T; Hu CJ
    Med Sci Monit; 2018 Mar; 24():1581-1587. PubMed ID: 29549708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization and evaluation of a sheathless capillary electrophoresis-electrospray ionization mass spectrometry platform for peptide analysis: comparison to liquid chromatography-electrospray ionization mass spectrometry.
    Faserl K; Sarg B; Kremser L; Lindner H
    Anal Chem; 2011 Oct; 83(19):7297-305. PubMed ID: 21848273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry.
    Chen J; Anderson M; Misek DE; Simeone DM; Lubman DM
    J Chromatogr A; 2007 Aug; 1162(2):117-25. PubMed ID: 17434173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics Analysis of Postoperative Epilepsy Seizures in Low-Grade Gliomas Using Preoperative MR Images.
    Sun K; Liu Z; Li Y; Wang L; Tang Z; Wang S; Zhou X; Shao L; Sun C; Liu X; Jiang T; Wang Y; Tian J
    Front Oncol; 2020; 10():1096. PubMed ID: 32733804
    [No Abstract]   [Full Text] [Related]  

  • 17. Biomarker identification in human pancreatic cancer sera.
    Hanas JS; Hocker JR; Cheung JY; Larabee JL; Lerner MR; Lightfoot SA; Morgan DL; Denson KD; Prejeant KC; Gusev Y; Smith BJ; Hanas RJ; Postier RG; Brackett DJ
    Pancreas; 2008 Jan; 36(1):61-9. PubMed ID: 18192883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum profiling to distinguish early- and late-stage ovarian cancer patients from disease-free individuals.
    Hocker JR; Bishop EA; Lightfoot SA; Lerner MR; Peyton MD; Brackett DJ; Hanas RJ; McMeekin DS; Walker JL; Hanas JS
    Cancer Invest; 2012 Feb; 30(2):189-97. PubMed ID: 22149058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum peptide profiling for potential biomarkers in early diagnosis of Escherichia coli bloodstream infection.
    Ma Y; Chen C; Yang M; He S; Zhang K; Wang C
    Cytokine; 2019 Aug; 120():71-77. PubMed ID: 31026733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.